Gilead price target raised to $100 from $95 at TD Cowen
TD Cowen raised the firm’s price target on Gilead (GILD) to $100 from $95 and keeps a Buy rating on the shares. The firm said they posted a ...
Gilead price target raised to $90 from $84 at RBC Capital
RBC Capital analyst Brian Abrahams raised the firm’s price target on Gilead (GILD) to $90 from $84 and keeps a Sector Perform rating on the ...
Gilead Quarterly Results Beat Estimates
Gilead said its fourth-quarter HIV product sales rose to $5.45 billion from $4.69 billion a year earlier, due to higher ...
HIV Infections Could Jump Over 6 Times if US Support Is Dropped and Not Replaced, UNAIDS Chief Says
The head of the U.N. AIDS agency says the number of new HIV infections could jump more than six times by 2029 if American ...
Diginomica2d
Agents of change - Salesforce's new top team for the 'Agentforce era'
Salesforce has announced a new CFO+ with an expanded set of responsibilities as a company veteran who "bleeds CRM" prepares ...
BizPac Review5d
Dem claims ‘Christian prayer’ should not be allowed in Capitol, protests National Prayer Breakfast
California Democratic Rep. Jared Hoffman protested the National Prayer Breakfast Thursday, claiming it violates the separation between church and state. The congressman said in an X video […] ...
Biden Rule Cleared Hurdles to Lifesaving HIV Drug, but Barriers Remain in Georgia
A new rule requires insurers to improve coverage of PrEP, which can prevent HIV, but Georgians face challenges getting the ...